Sacituzumab (powder)

Description

Sacituzumab powder is a humanized IgG1 monoclonal antibody targeting Trophoblast cell surface antigen 2 TROP2 . Sacituzumab powder demonstrates a lack of antitumor effects alone and does not inhibit the function of TROP-2 during tumor metastasis, binding to the linear epitopes of TROP-2 protein. Sacituzumab powder can be used for the synthesis of antibody-drug conjugates ADC drug Sacituzumab govitecan HY-132254 . Sacituzumab govitecan can be used in the field of triple-negative breast cancer.